title: Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report.
abstract: Asbestos is a mineral-mined form the rocks, consisting in amosite (brown asbestos), crocidolite (blue asbestos) and÷or chrysotile (white asbestos) used in many industries. Researches about the exposure to asbestos dust and asbestosis related diseases started almost a century ago. The first case report of fatal asbestosis disease was published in 1906, in England, by Dr. Hubert Montague Murray. A decade after, asbestos "curious bodies" were firstly described in the lung tissue by Cooke (1926) and McDonald (1927). Occupational exposure to asbestos is now regulated in Romania, but past exposure is still a cause of asbestosis-related diseases (ARDs), including lung cancer. A peculiar association between a lung adenocarcinoma, a previously healed pulmonary tuberculosis (PTB) disease, is reported in a 61-year-old nonsmoker white man, a former factory worker with 29 years of occupational exposure history to cement and asbestos fibers. The positive diagnosis of asbestos exposure was facilitated by asbestos bodies determined in bronchoalveolar lavage fluid. The main purpose of this case report is to describe the development of a right pleural effusion which was not revelatory for a mesothelioma but for an adenocarcinoma of the lung. An accurate morphologic and immunohistochemistry assessment of a pleural biopsy sample excluded mesothelioma and was crucial in the positive diagnosis of adenocarcinoma. In conclusion, unilateral paraneoplastic pleural effusion in a nonsmoker male with occupational exposure to asbestosis fibers was suggestive for adenocarcinoma related asbestosis of the lung. Lung cancer and malignant pleural exudate developed after a long latency cumulative retention time of asbestos fibers.
authors.affiliation: Department of Pneumology, University of Medicine and Pharmacy of Craiova, "Victor Babes" Clinical Hospital of Infectious Diseases and Pneumophthisiology, Craiova, Romania; dr_nitumimi@yahoo.com.
authors.forename: Agripina
authors.initials: A
authors.lastname: Raşcu
authors.forename: Eugenia
authors.initials: E
authors.lastname: Naghi
authors.forename: Marina Ruxandra
authors.initials: MR
authors.lastname: OŢelea
authors.forename: Floarea Mimi
authors.initials: FM
authors.lastname: NiŢu
authors.forename: Oana Cristina
authors.initials: OC
authors.lastname: Arghir
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology* / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D001195:Asbestosis / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000276:immunology* / Q000473:pathology; D008297:Male; D008654:Mesothelioma / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged